These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 6250854)
1. Macrophage requirement for in vitro generation of specific, secondary cell-mediated cytotoxicity against SV 40-induced tumor-associated antigens in mice. Glaser M Eur J Immunol; 1980 May; 10(5):342-6. PubMed ID: 6250854 [TBL] [Abstract][Full Text] [Related]
2. Effect of tumor cells on the generation of cytotoxic T lymphocytes in vitro. I. Accessory cell functions of mouse tumor cells in the generation of cytotoxic T lymphocytes in vitro: replacement of adherent phagocytic cells by tumor cells or 2-mercaptoethanol. Koren HS; Hodes RJ Eur J Immunol; 1977 Jun; 7(6):394-400. PubMed ID: 302208 [TBL] [Abstract][Full Text] [Related]
3. Generation of cytotoxic lymphocytes by SV40-induced antigens. Chang C; Chang R; Mora PT; Hu CP J Immunol; 1982 May; 128(5):2160-3. PubMed ID: 6278025 [TBL] [Abstract][Full Text] [Related]
4. Studies of the mechanisms for the induction of in vivo tumor immunity. IV. Enhancement of the in vitro generation of secondary cell-mediated cytotoxic response by normal peritoneal macrophages and their culture supernatants. Igarashi T; Rodrigues D; Ting CC J Immunol; 1979 Apr; 122(4):1519-27. PubMed ID: 156217 [TBL] [Abstract][Full Text] [Related]
5. Regulation of the in vitro secondary cell-mediated cytotoxic response against syngeneic FBL-3 leukemia by macrophages. Igarashi T; Teranishi T; Rodrigues D; Yamamura Y Microbiol Immunol; 1980; 24(6):599-72. PubMed ID: 6968022 [TBL] [Abstract][Full Text] [Related]
6. Tumor cell-triggered macrophage-mediated suppression of the T-cell cytotoxic response to tumor-associated antigens. I. Characterization of the cell components for induction of suppression. Ting CC; Rodrigues D J Natl Cancer Inst; 1982 Oct; 69(4):867-72. PubMed ID: 6214653 [TBL] [Abstract][Full Text] [Related]
7. Requirement of adherent/phagocytic cells for the induction of F1 anti-parent cell-mediated lympholysis. I. Parental adherent splenocytes serve as stimulators. Freimuth WW; Cudkowicz G J Immunol; 1981 Oct; 127(4):1504-9. PubMed ID: 7024408 [TBL] [Abstract][Full Text] [Related]
8. T-T cell synergy in the in vitro generation of secondary cell-mediated cytotoxicity against syngeneic SV-40 transformed cells. Glaser M J Immunol; 1979 Mar; 122(3):973-9. PubMed ID: 87423 [No Abstract] [Full Text] [Related]
9. Distinct proliferative T cell clonotypes are generated in response to a murine retrovirus-induced syngeneic T cell leukemia: viral gp70 antigen-specific MT4+ clones and Lyt-2+ cytolytic clones which recognize a tumor-specific cell surface antigen. Matis LA; Ruscetti SK; Longo DL; Jacobson S; Brown EJ; Zinn S; Kruisbeek AM J Immunol; 1985 Jul; 135(1):703-13. PubMed ID: 2582053 [TBL] [Abstract][Full Text] [Related]
10. Antigenic specificity of the cytolytic T lymphocyte (CTL) response to murine sarcoma virus-induced tumors. I. Preferential reactivity of in vitro generated secondary CTL with syngeneic tumor cells. Plata F; Jongeneel V; Cerottini JC; Brunner KT Eur J Immunol; 1976 Nov; 6(11):823-9. PubMed ID: 187429 [TBL] [Abstract][Full Text] [Related]
11. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [TBL] [Abstract][Full Text] [Related]
12. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice. Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223 [TBL] [Abstract][Full Text] [Related]
13. Cell growth and differentiation in vitro in mouse macrophages transformed by a tsA mutant of simian virus 40. I. Cellular response in proliferative and phagocytic activities to the shift of temperature differs depending on the culture state in mouse bone marrow cells transformed by the tsA640 mutant of simian virus 40. Tanigawa T; Takayama H; Takagi A; Kimura G J Cell Physiol; 1983 Sep; 116(3):303-10. PubMed ID: 6309870 [TBL] [Abstract][Full Text] [Related]
14. Requirement for recognition of class II molecules and processed tumor antigen for optimal generation of syngeneic tumor-specific class I-restricted CTL. Kern DE; Klarnet JP; Jensen MC; Greenberg PD J Immunol; 1986 Jun; 136(11):4303-10. PubMed ID: 2422280 [TBL] [Abstract][Full Text] [Related]
15. Accessory cell dependence of lectin-induced proliferation of mouse T lymphocytes. Habu S; Raff MC Eur J Immunol; 1977 Jul; 7(7):451-7. PubMed ID: 302211 [TBL] [Abstract][Full Text] [Related]
16. Immunization of BALB/c mice with recombinant simian virus 40 large tumor antigen induces antibody-dependent cell-mediated cytotoxicity against simian virus 40-transformed cells. An antibody-based mechanism for tumor immunity. Bright RK; Shearer MH; Kennedy RC J Immunol; 1994 Sep; 153(5):2064-71. PubMed ID: 8051411 [TBL] [Abstract][Full Text] [Related]
17. Cell surface expression of cytotoxic T lymphocyte-defined, AKR/Gross leukemia virus-associated tumor antigens by normal AKR.H-2b splenic B cells. Green WR J Immunol; 1983 Dec; 131(6):3078-84. PubMed ID: 6605998 [TBL] [Abstract][Full Text] [Related]
18. Functional activity in vivo of effector T cell populations. II. Anti-tumor activity exhibited by syngeneic anti-MoMULV-specific cytolytic T cell clones. Engers HD; Lahaye T; Sorenson GD; Glasebrook AL; Horvath C; Brunner KT J Immunol; 1984 Sep; 133(3):1664-70. PubMed ID: 6205090 [TBL] [Abstract][Full Text] [Related]
19. Generation of virus specific cytotoxic T cells in vitro. III. Spleen cells stimulated by viral antigens generate alloreactive cytotoxic T cells. Koszinowski U; Greber D; Neuschaefer-Rube I Immunobiology; 1979 Aug; 156(1-2):83-95. PubMed ID: 232074 [TBL] [Abstract][Full Text] [Related]
20. Cell-mediated immunity to Friend virus-induced leukemia. III. Characteristics of secondary cell-mediated cytotoxic response. Ting CC; Kirchner H; Rodrigues D; Park JY; Herberman RB J Immunol; 1976 Jan; 116(1):244-52. PubMed ID: 54388 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]